Pinitol - Humanetics

Drug Profile

Pinitol - Humanetics

Alternative Names: Cerebrate; NIC 515

Latest Information Update: 24 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mount Sinai School of Medicine
  • Developer Humanetics Corporation
  • Class Antidementias; Antihyperglycaemics; Insulin sensitisers; Nootropics; Small molecules; Sugar alcohols
  • Mechanism of Action Amyloid precursor protein secretase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alzheimer's disease

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 19 Jun 2015 Pinitol is still in phase-II development for Alzheimer's disease in USA
  • 02 Jun 2012 Phase IIb development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top